Meeting
2023 ASCO Annual Meeting
Development of a novel blood-based RNA gene expression platform for early-stage lung cancer diagnosis.
Authors
Martin J Keiser III
IV BioHoldings (IVBH), Newport Beach, CA
Martin J Keiser III, Elizabeth Cormier-May , Matthew Alderdice , Joy N Kavanagh , Brendon Matthew Stiles
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 8557)
DOI
10.1200/JCO.2023.41.16_suppl.8557
Abstract #
8557
Poster Bd #
184
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Assessment of electronic health record (EHR) –based machine learning (ML) in predicting risk of brain metastasis among patients with early-stage non–small-cell lung cancer (eNSCLC).
First Author: Hossein Honarvar
Poster
2023 ASCO Annual Meeting
Detecting early stage breast cancer using low-depth cell-free DNA fragmentomics: A multi-center cohort study.
First Author: Jiaqi Liu
Poster
2021 ASCO Annual Meeting
Accurate early-stage colorectal cancer detection through analysis of cell-free circulating tumor DNA (ctDNA) methylation patterns.
First Author: James M. Kinross
Poster
2021 ASCO Annual Meeting
Machine learning-based multiple cancer detections with circulating miRNA profiles in the blood.
First Author: Juntaro Matsuzaki